Taiwan is expected to review an application for emergency use authorization (EUA) of the Pfizer-BioNTech second-generation COVID-19 vaccine next week, Central Epidemic Command Center (CECC) head Victor Wang (王必勝) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan could mandate traceable washed eggs for national food chains
12/21/2024 10:03 PM - Society
TR could penalize man for trespassing on railway tracks
12/21/2024 09:24 PM - Society
5 injured in collision between Taichung bus and car
12/21/2024 08:21 PM - Science & Tech
Taiwan plans to set up drone testing facility in Chiayi
12/21/2024 06:25 PM - Cross-Strait
Experts sound alarm over low awareness of China threat among Taiwan's youth
12/21/2024 06:08 PM